WELBIO is an inter-university life sciences research institute based in Wallonia, Belgium. WELBIO aims at promoting scientific excellence in fundamental life sciences research and translating scientific achievements in medical, pharmaceutical and veterinary biotechnology applications.

Prof. Decio. Eizirik will present the keynote Ernst Knobil Lecture at the 38th IUPS

WELBIO is pleased to announce that Prof. Decio Eizirik, WELBIO investigator at the Université Libre de Bruxelles, has been invited to present the keynote Ernst Knobil Lecture at the 38th World Congress of the International Union of Physiological Sciences (IUPS-2017), to be held in Rio de Janeiro, Brazil, from August 1 to August 5, 2017.

Identification of susceptibility biomarkers to new anti-CDK4 drugs in breast cancer

New progress in treating breast cancer. Prof. Raspé and Roger’s team (WELBIO - IRIBHM – ULB), in collaboration with the Institut Jules Bordet, identified the activating phosphorylation on T172 of CDK4, as the most relevant biomarker to predict the response to palbociclib. The results of this study have been published in EMBO Molecular Medicine.

Discovery : how rhinovirus exacerbates asthmatic reactions

A collaborative study led in the laboratories of Prof. Fabrice Bureau (Welbio investigator at ULg), Dr. Thomas Marichal and Sebastian Johnston (Professor at Imperial College London and Director of the MRC & Asthma UK in Allergic Mechanisms of Asthma) helps to elucidate how the virus responsible for the seasonal cold shapes our immune system to promote severe exacerbations of asthma in individuals suffering from their disease. The results of this study haves been published in Nature Medicine.

All news

June 23, 2017 - 12:11 AM - URL: http://welbio.org/cms/c_8241/en/accueil